[{"AccountsPayableCurrent_0_Q2_USD":14658000.0,"OtherAssetsNoncurrent_0_Q2_USD":49962000.0,"OtherAssetsCurrent_0_Q2_USD":131045000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":781000.0,"OperatingIncomeLoss_2_Q2_USD":-164940000.0,"OperatingIncomeLoss_1_Q2_USD":-72969000.0,"NumberOfOperatingSegments_2_Q2_Segment":2.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"NetIncomeLoss_2_Q2_USD":-170744000.0,"NetIncomeLoss_1_Q2_USD":-80875000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-117314000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-22174000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":306965000.0,"LongTermLoansFromBank_0_Q2_USD":60019000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-1697000.0,"LiabilitiesCurrent_0_Q2_USD":293825000.0,"Liabilities_0_Q2_USD":1914395000.0,"InvestmentIncomeNet_2_Q2_USD":7364000.0,"InvestmentIncomeNet_1_Q2_USD":2734000.0,"InventoryWorkInProcess_0_Q2_USD":954000.0,"InventoryRawMaterials_0_Q2_USD":21586000.0,"InventoryNet_0_Q2_USD":24099000.0,"InventoryFinishedGoods_0_Q2_USD":1559000.0,"InterestPaidNet_2_Q2_USD":2866000.0,"InterestExpense_2_Q2_USD":4771000.0,"InterestExpense_1_Q2_USD":2357000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-9179000.0,"IncreaseDecreaseInOtherEmployeeRelatedLiabilities_2_Q2_USD":-35506000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-14914000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2134000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2497069000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-4703000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":104000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":-22000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":140962000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":140866000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q2_USD":1882000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_2_Q2_USD":9642000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":582674000.0,"StockholdersEquity_0_Q2_USD":582674000.0,"ShareBasedCompensation_2_Q2_USD":67882000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":117653000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":56455000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":237357000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":125750000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1302050000.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":256963000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":179316000.0,"ProfitLoss_2_Q2_USD":-170744000.0,"ProfitLoss_1_Q2_USD":-80875000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":727859000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-1697000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-4703000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-189000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-186000.0,"PaymentsForHedgeFinancingActivities_2_Q2_USD":136620000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-50476000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":15551000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":740721000.0,"PaymentsToAcquireOtherProductiveAssets_2_Q2_USD":3182000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6130000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":632500000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":9642000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":89752000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":15795000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":140962000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-52200000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2819000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-175469000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-82468000.0,"CommonStockValue_0_Q2_USD":141000.0,"CommonStockSharesOutstanding_0_Q2_shares":141021583.0,"CommonStockSharesIssued_0_Q2_shares":141021583.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":167455000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":565119000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":565119000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":1494151000.0,"AssetsCurrent_0_Q2_USD":2238418000.0,"Assets_0_Q2_USD":2497069000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1137000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"AmortizationOfFinancingCosts_2_Q2_USD":2193000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":30022000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2_Q2_USD":89752000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":89752000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":67882000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":30022000.0,"AdjustmentsToAdditionalPaidInCapitalOther_2_Q2_USD":-136620000.0,"AdjustmentsToAdditionalPaidInCapitalOther_1_Q2_USD":-136620000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":15795000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":458000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1910379000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-25796000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":75150000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":1875000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-8824000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":67882000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-82468000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-175469000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":457000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":327000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-170287000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-80548000.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":827000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-8627000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-8627000.0,"GainLossOnInvestments_2_Q2_USD":873000.0,"GainLossOnInvestments_1_Q2_USD":860000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":29373000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":30222000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-22000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.21,"EarningsPerShareDiluted_1_Q2_USD":-0.57,"EarningsPerShareBasic_2_Q2_USD":-1.21,"EarningsPerShareBasic_1_Q2_USD":-0.57,"Depreciation_2_Q2_USD":7951000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":24004000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":102072000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":379874000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":26800000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":51400000.0,"ConvertibleDebtCurrent_0_Q2_USD":61876000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":551000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":2958000.0,"CostsAndExpenses_1_Q2_USD":198719000.0,"CostsAndExpenses_2_Q2_USD":402297000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":572099000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":629000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q2_Investment":494.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CostOfGoodsAndServicesSold_2_Q2_USD":5537000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":140866000.0,"Ticker":"IONS","CIK":"874015","name":"IONIS PHARMACEUTICALS INC","OfficialName":"Ionis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5803570258.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]